Publications Database

American Society of Health-System Pharmacists (2011)

Olanzapine.

American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2010)

Pentoxifylline.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2017)

Risperidone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Speech-Language-Hearing Association (2004)

Auditory integration training.

Rockville, MD: American Speech-Language-Hearing Association

Read Full (New Window)

American Speech-Language-Hearing Association

Autism (autism spectrum disorder).

Washington, DC: American Speech-Language-Hearing Association

Read Full (New Window)

American Speech-Language-Hearing Association

Autism.

Washington, DC: American Speech-Language-Hearing Association

Read Full (New Window)

American Speech-Language-Hearing Association (2006)

Guidelines for speech-language pathologists in diagnosis, assessment, and treatment of autism spectrum disorders across the life span.

Washington, DC: American Speech-Language-Hearing Association

Read Full (New Window)

American Veterinary Medical Association (2007)

Wellness guidelines for animals in animal-assisted activity, animal-assisted therapy, and resident animal programs.

Schaumburg, IL: American Veterinary Medical Association

Read Full (New Window)

Ames M. E. et al. (2016)

Overview and evaluation of a mentorship program for university students with ASD.

Focus on Autism and Other Developmental Disabilities

March, 31(1), pp. 27-36.

Read Abstract (New Window)

Amiet C. et al. (2008)

Epilepsy in autism is associated with intellectual disability and gender: Evidence from a meta-analysis.

Biological Psychiatry

64(7), pp. 577-582

Read Abstract (New Window)

Amirabdollahian F. et al. (2011)

Investigating tactile event recognition in child-robot interaction for use in autism therapy.

Conf Proc IEEE Eng Med Biol Soc

pp. 5347-51

Read Abstract (New Window)

Amminger G. et al. (2007)

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

Biological Psychiatry

61(4), 551-553

Read Abstract (New Window)

Anagnostou E. et al. (2014)

Autism spectrum disorder: advances in evidence-based practice.

Canadian Medical Association Journal

186(7),

Read Full (New Window)

Anagnostou E.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

Current Opinion in Neurology

Read Abstract (New Window)

Anagnostou E. et al. (2006)

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Journal of Clinical Psychopharmacology

26(4), pp. 444-446

Anagnostou E. et al. (2014)

Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth.

Brain Research

pii: S0006-8993(14)00134-6

Read Abstract (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Anagnostou E. et al.

Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial.

JAMA Psychiatry

Read Abstract (New Window)

Anckarsäter H. et al. (2008)

Autism spectrum disorders in institutionalized subjects.

Nordic Journal of Psychiatry

62(2), pp. 160-167

Read Abstract (New Window)